Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shaun Bhatty, Asghar Ali, Ranjith Shetty, Kevin F Sumption, On Topaz & Ion S Jovin. (2014) Contemporary anticoagulation therapy in patients undergoing percutaneous intervention. Expert Review of Cardiovascular Therapy 12:4, pages 451-461.
Read now
Read now
Bishoy Faltas. (2010) Prolonged and increased postoperative risk of venous thromboembolism: rationale for even more ‘extended’ prophylaxis?. Expert Review of Hematology 3:2, pages 161-163.
Read now
Read now
Articles from other publishers (6)
Paolo Prandoni, Sally Temraz & Ali Taher. (2014) Direct Oral Anticoagulants in the Prevention of Venous Thromboembolism: Evidence From Major Clinical Trials. Seminars in Hematology 51:2, pages 121-130.
Crossref
Crossref
Jihane Abou Rahal, Zaher K. Otrock, Joseph E. Maakaron & Ali Taher. 2012. Vascular Surgery. Vascular Surgery
331
338
.
Robert J. Young. (2011) The successful quest for oral factor Xa inhibitors; learnings for all of medicinal chemistry?. Bioorganic & Medicinal Chemistry Letters 21:21, pages 6228-6235.
Crossref
Crossref
Robert J. Young, Carl Adams, Mike Blows, David Brown, Cynthia L. Burns-Kurtis, Chuen Chan, Laiq Chaudry, Máire A. Convery, David E. Davies, Anne M. Exall, Graham Foster, John D. Harling, Eric Hortense, Stephanie Irvine, Wendy R. Irving, Steve Jackson, Savvas Kleanthous, Anthony J. Pateman, Angela N. Patikis, Theresa J. Roethka, Stefan Senger, Gary J. Stelman, John R. Toomey, Robert I. West, Caroline Whittaker, Ping Zhou & Nigel S. Watson. (2011) Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs. Bioorganic & Medicinal Chemistry Letters 21:6, pages 1582-1587.
Crossref
Crossref
Yu‐Kai Lee & Mark R. Player. (2011) Developments in factor Xa inhibitors for the treatment of thromboembolic disorders. Medicinal Research Reviews 31:2, pages 202-283.
Crossref
Crossref
Jonathan M. Plumb, Andreas Clemens & Brigitta U. Monz. (2010) Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:. PharmacoEconomics 28:9, pages 781-782.
Crossref
Crossref